Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Exagen Inc XGN

Healthcare Medical Care
Exagen Inc. is a provider of autoimmune testing and its purpose as an organization is to provide clarity in autoimmune disease decision-making. The Company has developed and is commercializing a portfolio of testing products, under its AVISE brand. It commercially launched its testing product, AVISE CTD, which enables differential diagnosis for patients presenting with symptoms indicative of a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:XGN)

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 Results and Business Highlights

GlobeNewswire 12 days ago

Exagen Inc. to Announce Fourth Quarter and Full-Year 2024 Financial Results on March 11, 2025

GlobeNewswire February 25, 2025

Exagen Inc. to Participate in Upcoming Investor Conferences

GlobeNewswire February 4, 2025

Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial Results

GlobeNewswire January 12, 2025

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

GlobeNewswire December 12, 2024

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform

GlobeNewswire November 14, 2024

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

GlobeNewswire November 13, 2024

Exagen Inc. Reports Third Quarter 2024 Results

GlobeNewswire November 12, 2024

Exagen to Announce Third Quarter 2024 Results on November 12, 2024

GlobeNewswire October 29, 2024
View More News ››

Opinion & Analysis (NDAQ:XGN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:XGN)

Exagen Inc. to Participate in the KeyBanc Capital Markets&#x

BREAKING NEWS: $XGN Exagen Inc. to Participate in the KeyBanc Capital Markets&#xA0;Life Sciences & MedTech Investor...
whytestocks - March 8, 2024

EXAGEN: ENABLING TIMELY DIAGNOSIS FOR LUPUS PATIENTS

$XGN  Excited to share an article about Exagen Inc. (NASDAQ: XGN), a provider of autoimmune testing solutions. ...
AviseAnalytics - February 20, 2024
View more Bullboard ››

Spirit Blockchain Capital Inc.

Spirit Blockchain Capital Inc.

Spirit Blockchain Capital Inc. is an investment company focused on blockchain industry. Through its operational business line ...
View More »